SARS-CoV-2感染对辅助生殖妊娠结局的影响
该研究通过欧洲人类生殖与胚胎学会(ESHRE)组织的自愿数据收集,分析了2020年5月至2021年6月间80例辅助生殖后感染SARS-CoV-2的妊娠病例,来自32个国家。结果显示,辅助生殖妊娠与自然妊娠相比,SARS-CoV-2感染的影响无差异。数据可用于指导疫情期间辅助生殖妊娠女性的临床决策。
要点
- 辅助生殖妊娠不因SARS-CoV-2感染而受到差异化影响。
- 80例中67例活产、10例流产、2例死产、1例孕产妇死亡。
- 数据来自32个国家,另有25例妊娠仍在进行中。
核心结论
- 辅助生殖妊娠与自然妊娠相比,SARS-CoV-2感染对妊娠结局的影响无差异。
研究设计与样本
- 通过ESHRE组织的自愿在线数据收集,收集2020年5月至2021年6月SARS-CoV-2感染的辅助生殖妊娠数据。
- 数据集包括来自32个国家的80例病例。
主要发现
- 80例中包括67例活产、10例流产、2例死产和1例孕产妇死亡。
- 另有25例妊娠在写作时仍在进行中。
临床怎么用
- 当前数据可用于指导COVID-19大流行期间辅助生殖妊娠女性的临床决策。
局限性
- 基于自愿贡献的国际数据登记可能受选择性报告影响,存在高估或低估的风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: What is the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on the outcome of a pregnancy after medically assisted reproduction (MAR)? SUMMARY ANSWER: Our results suggest that MAR pregnancies are not differentially affected by SARS-CoV-2 infection compared to spontaneous pregnancies. WHAT IS KNOWN ALREADY: Information on the effects of coronavirus disease 2019 (COVID-19) on pregnancy after MAR is scarce when women get infected during MAR or early pregnancy, even though such information is vital for informing women seeking pregnancy. STUDY DESIGN, SIZE, DURATION: Data from SARS-CoV-2 affected MAR pregnancies were collected between May 2020 and June 2021 through a voluntary data collection, organised by the European Society of Human Reproduction and Embryology (ESHRE). PARTICIPANTS/MATERIALS, SETTING, METHODS: All ESHRE members were invited to participate to an online data collection for SARS-CoV-2-infected MAR pregnancies. MAIN RESULTS AND THE ROLE OF CHANCE: The dataset includes 80 cases from 32 countries, including 67 live births, 10 miscarriages, 2 stillbirths and 1 maternal death. An additional 25pregnancies were ongoing at the time of writing. LIMITATIONS, REASONS FOR CAUTION: An international data registry based on voluntary contribution can be subject to selective reporting with possible risks of over- or under-estimation. WIDER IMPLICATIONS OF THE FINDINGS: The current data can be used to guide clinical decisions in the care of women pregnant after MAR, in the context of the COVID-19 pandemic. STUDY FUNDING/COMPETING INTEREST(S): The authors acknowledge the support of ESHRE for the data registry and meetings. J.S.T. reports grants or contracts from Sigrid Juselius Foundation, EU and Helsinki University Hospital Funds, outside the scope of the current work. The other authors declare that they have no conflict of interest. TRIAL REGISTRATION NUMBER: N/A.
引用
- Ata B, Gianaroli L, Lundin K, et al. Outcomes of SARS-CoV-2 infected pregancies after medically assisted reproduction. Hum Reprod. 2021. PMID: 34515777. doi:10.1093/humrep/deab218
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。